Katharina Hopp Selected Research

Katharina Hopp Research Topics

Disease

18	Autosomal Dominant Polycystic Kidney (ADPKD) 04/2024 - 01/2015
9	Cysts 04/2024 - 04/2009
5	Polycystic Kidney Diseases (Polycystic Kidney Disease) 10/2023 - 02/2015
5	Neoplasms (Cancer) 01/2023 - 01/2019
4	Disease Progression 10/2023 - 01/2020
4	Inflammation (Inflammations) 01/2023 - 01/2022
2	Ureteral Obstruction 01/2022 - 01/2019
2	Fibrosis (Cirrhosis) 01/2022 - 01/2019
2	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2019
2	Lewis Lung Carcinoma 01/2020 - 01/2019
1	Insulin Resistance 04/2024
1	Overweight 01/2022
1	Weight Loss (Weight Reduction) 01/2022
1	Dysbiosis 01/2022
1	Reperfusion Injury 01/2022
1	Kidney Diseases (Kidney Disease) 01/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2020
1	Adenocarcinoma of Lung 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2020
1	Tuberous Sclerosis (Bourneville's Disease) 11/2019
1	Ciliopathies 11/2019
1	Autosomal Recessive Polycystic Kidney (Polycystic Kidney Disease, Infantile, Type I) 11/2019
1	Chronic Renal Insufficiency 01/2019
1	Liver Diseases (Liver Disease) 01/2016
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2016
1	Intracranial Aneurysm (Cerebral Aneurysm) 01/2016
1	Polycystic liver disease 01/2016
1	Primary Hyperoxaluria (Oxaluria, Primary) 10/2015
1	Hypertrophy 01/2015

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2016
4	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2019
3	Sirolimus (Rapamycin)FDA Link 11/2019 - 01/2016
2	EnzymesIBA 10/2023 - 01/2023
2	Tryptophan (L-Tryptophan)FDA Link 10/2023 - 01/2023
2	KynurenineIBA 01/2023 - 01/2021
2	CytokinesIBA 01/2022 - 01/2022
2	Biomarkers (Surrogate Marker)IBA 10/2021 - 12/2019
2	Mechanistic Target of Rapamycin Complex 1IBA 11/2020 - 01/2019
2	Tolvaptan FDA Link 01/2020 - 01/2015
2	polycystic kidney disease 1 proteinIBA 11/2019 - 04/2009
2	Phosphotransferases (Kinase)IBA 01/2019 - 01/2016
1	Insulin (Novolin)FDA Link 04/2024
1	CreatinineIBA 04/2024
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 10/2023
1	Kynurenic Acid (Kynurenate)IBA 01/2023
1	Immune Checkpoint InhibitorsIBA 01/2023
1	Interleukin-6 (Interleukin 6)IBA 01/2023
1	Malondialdehyde (Propanedial)IBA 01/2022
1	InterferonsIBA 01/2022
1	glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA 01/2022
1	anandamide (arachidonylethanolamide)IBA 01/2022
1	PolyaminesIBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA 01/2022
1	EndocannabinoidsIBA 01/2022
1	AnaphylatoxinsIBA 01/2022
1	HomocysteineIBA 01/2022
1	methionine sulfoxideIBA 01/2022
1	S-AdenosylhomocysteineIBA 01/2022
1	AllantoinIBA 01/2022
1	IndolesIBA 01/2022
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 01/2022
1	AsparagineIBA 01/2021
1	Arginine (L-Arginine)FDA Link 01/2021
1	Pravastatin (Pravachol)FDA LinkGeneric 01/2021
1	TrehaloseIBA 11/2020
1	Autophagy-Related ProteinsIBA 11/2020
1	Amino Acids FDA Link 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	LipidsIBA 01/2020
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 12/2019
1	Tuberous Sclerosis Complex 2 ProteinIBA 11/2019
1	polycystic kidney disease 2 proteinIBA 11/2019
1	TRPP Cation ChannelsIBA 11/2019
1	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 01/2019
1	Mechanistic Target of Rapamycin Complex 2IBA 01/2019
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2019
1	zileuton (Zyflo)FDA Link 01/2019
1	LeukotrienesIBA 01/2019
1	Immunoglobulin G (IgG)IBA 12/2018
1	ChemokinesIBA 12/2018
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2016
1	GlucosidasesIBA 01/2016
1	CalciumIBA 01/2016
1	4-nitrophenyl-alpha-glucosidaseIBA 01/2016
1	GurIBA 01/2016
1	diethylstilbestrol monophosphate (PDES)IBA 01/2016
1	AMP-Activated Protein KinasesIBA 01/2016
1	1-dodecylpyridoxal (PLD)IBA 01/2016
1	OxalatesIBA 10/2015
1	Vasopressins (Vasopressin)IBA 02/2015
1	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 02/2015
1	Adenosine Monophosphate (AMP)IBA 01/2015
1	pasireotideIBA 01/2015
1	adenylyl cyclase 6IBA 01/2015

Therapy/Procedure

5	Therapeutics 01/2021 - 01/2015
1	Caloric Restriction 01/2022
1	Immunotherapy 01/2020
1	Transplantation 01/2016